“…Magnetic Resonance Imaging (MRI) is a valuable, non-invasive tool for studying the macrostructural changes characterizing the AD spectrum [ [4] , [5] , [6] , [7] , [8] , [9] , [10] , [11] ; Table 1 ]. Neuroimaging research has primarily focused on medial temporal structures, such as the hippocampus [ [12] , [13] , [14] , [15] , [16] , [17] , [18] ] and, more recently, the amygdala [ [19] , [20] , [21] ]. These regions are of particular interest as they exhibit early signs of tau pathology, a process strongly associated with neurodegeneration and cognitive decline in AD [ 19 , 20 , [22] , [23] , [24] , [25] , [26] , [27] ].…”